{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:46:22Z","timestamp":1780512382130,"version":"3.54.1"},"reference-count":19,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,7,1]]},"abstract":"<jats:p>Very long chain fatty acid dehydrogenase (VLCAD) deficiency is a rare but treatable cause of cardiomyopathy, fatty liver, skeletal myopathy, pericardial effusions, ventricular arrhythmias, and sudden death. Unrecognized, VLCAD deficiency may be rapidly progressive and fatal, secondary to its cardiac involvement. Because early diagnosis improves outcome, we present a neonate with VLCAD deficiency in whom retrospective analysis of the newborn screening card revealed that a correct diagnosis could have been made by newborn screening using tandem mass spectrometry.<\/jats:p>\n               <jats:p>Our patient demonstrated a classic neonatal course with transient hypoglycemia at birth, interpreted as culture-negative sepsis, followed by a quiescent period notable only for hypotonia and poor feeding. At 3 months, he presented with cardiorespiratory failure and pericardial effusions, requiring pericardiocentesis, tracheostomy, and prolonged mechanical ventilation. Plasma free-fatty acid and acylcarnitine profiles demonstrated small but significant elevations of C14:2, C14:1, C16, and C18:1 acylcarnitine species, findings consistent with a biochemical diagnosis of VLCAD deficiency. Enteral feeds were changed to Portagen formula with marked improvement in cardiac symptoms over several weeks.<\/jats:p>\n               <jats:p>To confirm the biochemical diagnosis, molecular analysis was performed by analysis of genomic DNA on a blood sample of the patient. Sequencing analysis and delineation of VLCAD mutations were performed using polymerase chain reaction and genomic sequencing. The patient was heterozygous for 2 different disease-causing mutations at the VLCAD locus. The maternal mutation was a deletion of bp 842\u20133 in exon 8, causing a shift in the reading frame. The paternal mutation was G+1A in the consensus donor splice site after exon 1; this splice-site mutation would likely result in decreased mRNA. The likely consequence of these mutations is essentially a null phenotype.<\/jats:p>\n               <jats:p>To determine whether this case could have been picked up by tandem mass spectrometry analysis at birth when the patient was asymptomatic, acylcarnitine analysis was performed on the patient's original newborn card (after obtaining parental consent, the original specimen was provided courtesy of Dr Kenneth Pass, Director, New York State Newborn Screening Program). The blood sample had been obtained at 1 week of age and stored at room temperature for 6 months and at 70\u00b0C thereafter for 18 months. Electrospray tandem mass spectrometry used a LC-MS\/MS API 2000 operated in ion evaporation mode with the TurboIonSpray ionization probe source.<\/jats:p>\n               <jats:p>The acylcarnitine profile obtained from the patient's original newborn card was analyzed 2 years after it was obtained. In comparison with a normal control, there was a significant accumulation of long chain acylcarnitine species, with a prominent peak of tetradecenoylcarnitine (C14:1), the most characteristic metabolic marker of VLCAD deficiency. This profile would have likely been even more significant if it had been analyzed at the time of collection, yet 2 years later is sufficient to provide strong biochemical evidence of the underlying disorder.<\/jats:p>\n               <jats:p>Discussion.\u2003VLCAD was first discovered in 1992, and clinical experience with VLCAD deficiency has been accumulating rapidly. Indeed, the patients originally diagnosed with long chain acyl-CoA deficiency suffer instead from VLCAD deficiency. The phenotype of VLCAD deficiency is heterogeneous, ranging from catastrophic metabolic and cardiac failure in infancy to mild hypoketotic, hypoglycemia, and exertional rhabdomyolysis in adults. This case demonstrates that VLCAD deficiency could have been detected from the patient's own neonatal heel-stick sample. Most likely, a presymptomatic diagnosis would have avoided at least part of a lengthy and intensive prediagnosis hospitalization that had an estimated cost of $400\u2009000.<\/jats:p>\n               <jats:p>Although VLCAD is relatively rare, timely and correct diagnosis leads to dramatic recovery, so that detection by newborn screening could prevent the onset of arrhythmias, heart failure, metabolic insufficiency, and death. Fatty acid oxidation defects, including VLCAD deficiency, may account for as many as 5% of sudden infant death patients. Recent instrumentation advances have made automated tandem mass spectrometry of routine neonatal heel-stick samples technically feasible. Pilot studies have demonstrated an incidence of fatty acid oxidation defects, including short chain, medium chain, and very long chain acyl-CoA dehydrogenase deficiencies, of approximately 1\/12\u2009000. As a result, cost-benefit ratios for this approach should be systematically examined.<\/jats:p>","DOI":"10.1542\/peds.108.1.e19","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:55:51Z","timestamp":1092441351000},"page":"e19-e19","source":"Crossref","is-referenced-by-count":55,"title":["Diagnosis of Very Long Chain Acyl-Dehydrogenase Deficiency From an Infant's Newborn Screening Card"],"prefix":"10.1542","volume":"108","author":[{"given":"John C.","family":"Wood","sequence":"first","affiliation":[{"name":"From the Division of Cardiology, Department of Pediatrics, University of Southern California School of Medicine, Children's Hospital of Los Angeles, Los Angeles, California;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Magera","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Department of Laboratory Medicine and Pathology, Biochemical Genetics Laboratory, Rochester, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Rinaldo","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Department of Laboratory Medicine and Pathology, Biochemical Genetics Laboratory, Rochester, Minnesota;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margretta Reed","family":"Seashore","sequence":"additional","affiliation":[{"name":"Department of Genetics, Yale School of Medicine, New Haven, Connecticut;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold W.","family":"Strauss","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Friedman","sequence":"additional","affiliation":[{"name":"Section of Pediatric Cardiology, Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2001,7,1]]},"reference":[{"key":"2021121010110033600_B1","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1172\/JCI117947","article-title":"Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients.","volume":"95","author":"Aoyama","year":"1995","journal-title":"J Clin Invest"},{"key":"2021121010110033600_B2","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/01.CIR.100.22.2248","article-title":"Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.","volume":"100","author":"Bonnet","year":"1999","journal-title":"Circulation"},{"key":"2021121010110033600_B3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1161\/01.CIR.99.10.1337","article-title":"Molecular heterogeneity in very-long-chain acyl-coA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death.","volume":"99","author":"Mathur","year":"1999","journal-title":"Circulation"},{"key":"2021121010110033600_B4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0009-8981(97)00185-X","article-title":"Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients.","volume":"269","author":"Vianey-Saban","year":"1998","journal-title":"Clin Chim Acta"},{"key":"2021121010110033600_B5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0022-3476(97)80073-X","article-title":"Very long chain acyl-coenzyme A dehydrogenase deficiency in two siblings: evolution after prenatal diagnosis and prompt management.","volume":"131","author":"Sluysmans","year":"1996","journal-title":"J Pediatr"},{"key":"2021121010110033600_B6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1097-0223(199602)16:2<117::AID-PD820>3.0.CO;2-Z","article-title":"Prenatal diagnosis of mitochondrial fatty acid oxidation defects.","volume":"16","author":"Nada","year":"1996","journal-title":"Prenat Diagn"},{"key":"2021121010110033600_B7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-3476(98)70228-8","article-title":"Reversal of severe hypertrophic cardiomyopathy and excellent neuropsychologic outcome in very-long-chain acyl-coenzyme A dehydrogenase deficiency.","volume":"133","author":"Cox","year":"1998","journal-title":"J Pediatr"},{"key":"2021121010110033600_B8","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/clinchem\/43.11.2106","article-title":"Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry.","volume":"43","author":"Chace","year":"1997","journal-title":"Clin Chem"},{"key":"2021121010110033600_B9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1203\/00006450-199509000-00009","article-title":"Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry.","volume":"38","author":"Rashed","year":"1995","journal-title":"Pediatr Res"},{"key":"2021121010110033600_B10","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0021-9258(18)48391-3","article-title":"Novel fatty acid B-oxidation enzymes in rat liver mitochondria. II. Purification and properties of enoyl-coenzyme A (CoA) hydratase\/3-hydroxyacyl-CoA dehydrogenase\/3-ketoacyl-CoA thiolase trifunctional protein.","volume":"267","author":"Uchida","year":"1992","journal-title":"J Biol Chem"},{"key":"2021121010110033600_B11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1203\/00006450-199307000-00025","article-title":"Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency.","volume":"34","author":"Yamaguchi","year":"1993","journal-title":"Pediatr Res"},{"key":"2021121010110033600_B12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/bmme.1996.0033","article-title":"Very long chain acyl-CoA dehydrogenase deficiency: successful treatment of acute cardiomyopathy.","volume":"58","author":"Brown-Harrison","year":"1996","journal-title":"Biochem Mol Med"},{"key":"2021121010110033600_B13","first-page":"36A","article-title":"Deficient activity of membrane bound very long chain acyl-coA dehydrogenase (VLCAD) in twin boys. Clinical, biochemical, and morphological observations [abstract]","volume":"35","author":"Hug","year":"1993","journal-title":". Pediatr Res"},{"key":"2021121010110033600_B14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1023\/A:1005553907216","article-title":"Adolescent myopathic presentation in two sisters with very long-chain acyl-CoA dehydrogenase deficiency.","volume":"22","author":"Merinero","year":"1999","journal-title":"J Inherit Metab Dis"},{"key":"2021121010110033600_B15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.410430422","article-title":"Very long chain Acyl-Coenzyme A dehydrogenase deficiency with adult onset.","volume":"43","author":"Smelt","year":"1997","journal-title":"Ann Neurol"},{"key":"2021121010110033600_B16","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0022-3476(98)70385-3","article-title":"Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life.","volume":"132","author":"Boles","year":"1998","journal-title":"J Pediatr"},{"key":"2021121010110033600_B17","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1177\/0883073899014001021","volume":"14","author":"Naylor","year":"1999","journal-title":"J Child Neurol."},{"key":"2021121010110033600_B18","first-page":"339","article-title":"The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders.","volume":"375","author":"Millington","year":"1992","journal-title":"Prog Clin Biol Res"},{"key":"2021121010110033600_B19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00125817-200007000-00011","article-title":"Tandem mass spectrometry in newborn screening.","volume":"2","author":"Charrow","year":"2000","journal-title":"Genet Medicine"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/108\/1\/e19\/893606\/e19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/108\/1\/e19\/893606\/e19.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T22:33:10Z","timestamp":1639175590000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/108\/1\/e19\/66797\/Diagnosis-of-Very-Long-Chain-Acyl-Dehydrogenase"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7,1]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2001,7,1]]},"published-print":{"date-parts":[[2001,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.108.1.e19","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2001,7,1]]}}}